Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia

Table 1

Sociodemographic and clinical characteristics of the patients ().

Sociodemographic/clinical variable
Age (years), mean (SD)	26.33 (6.08)
Duration of illness (months), mean (SD)	32.80 (29.85)
Age of onset (years), mean (SD)	23.67 (4.92)
Drug free period () (months), mean (SD)	31.85 (35.50)
Olanzapine dosage (milligrams), mean (SD)	19.0 (3.87)
Education, (%)
<10 years	7 (46.6)
>10 years	8 (53.4)
Occupation, (%)
Employed	11 (83.3)
Unemployed	4 (26.7)
Marital status, (%)
Single	10 (46.7)
Married	5 (33.3)
Family income, (%)
Low	14 (93.3)
High	1 (6.7)
Family type, (%)
Nuclear	4 (26.7)
Joint	11 (73.3)
Residence, (%)
Rural	12 (80.0)
Urban	3 (20.0)
Family psychiatric illness, (%)
Non-affective	5 (33.3)
Affective	1 (6.7)
Schizophrenia subtype, (%)
Paranoid	9 (60.0)
Undifferentiated	6 (40.0)
Drug status, (%)
Drug naive	8 (53.3)
Drug free	7 (46.7)
Side-effects, (%)
Sedation	9 (60)
Rigidity	3 (20)
Tremor	3 (20)
Constipation	1 (6.7)
Orthostatic hypotension	1 (6.7)